Holen Sie sich die Stockscreener-App
8.91
1.87%
-0.17
Schlusskurs vom Vortag:
$9.08
Offen:
$9.09
24-Stunden-Volumen:
505.78K
Relative Volume:
1.10
Marktkapitalisierung:
$1.28B
Einnahmen:
$6.32B
Nettoeinkommen (Verlust:
$230.14M
KGV:
9.2832
EPS:
0.9598
Netto-Cashflow:
$256.03M
1W Leistung:
-7.86%
1M Leistung:
-12.13%
6M Leistung:
-0.22%
1J Leistung:
-31.25%
1-Tages-Spanne:
$8.84
$9.375
1-Wochen-Bereich:
$8.84
$9.70
52-Wochen-Spanne:
$7.71
$15.48
Ardent Health Inc Stock (ARDT) Company Profile
Firmenname
Ardent Health Inc
Sektor
Branche
Telefon
(615) 296-3000
Adresse
340 SEVEN SPRINGS WAY, BRENTWOOD
Compare ARDT vs HCA, THC, DVA, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARDT
Ardent Health Inc
|
8.91 | 1.28B | 6.32B | 230.14M | 256.03M | 0.9598 |
HCA
Hca Healthcare Inc
|
375.17 | 83.23B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
172.57 | 14.86B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
207.91 | 13.34B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
23.59 | 12.67B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
98.03 | 9.72B | 6.07B | 793.80M | 464.40M | 5.9914 |
Ardent Health Inc Stock (ARDT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-17 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-11-14 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-10-14 | Eingeleitet | Goldman | Neutral |
| 2025-09-10 | Eingeleitet | UBS | Buy |
| 2025-07-16 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-11-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-08-12 | Eingeleitet | BofA Securities | Buy |
| 2024-08-12 | Eingeleitet | Citigroup | Buy |
| 2024-08-12 | Eingeleitet | JP Morgan | Neutral |
| 2024-08-12 | Eingeleitet | Leerink Partners | Outperform |
| 2024-08-12 | Eingeleitet | Loop Capital | Buy |
| 2024-08-12 | Eingeleitet | Mizuho | Outperform |
| 2024-08-12 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-08-12 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-08-12 | Eingeleitet | Stephens | Overweight |
| 2024-08-12 | Eingeleitet | Truist | Buy |
Alle ansehen
Ardent Health Inc Aktie (ARDT) Neueste Nachrichten
Layoffs, closures tracker: MU Health Care cuts 74 employees - Modern Healthcare
Ardent Health Partners Inc (ARDT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Ardent Health Partners Inc (ARDT) Institutional Confidence - TradingKey
Ardent Health Partners Inc (ARDT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Ardent Health Partners Inc (ARDT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Ardent Health Partners Inc (ARDT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Ardent Health Partners Inc (ARDT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Ardent Health Partners Inc (ARDT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Ardent Health Partners Inc (ARDT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ardent Health, Inc. (ARDT) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
2026-06-14 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ardent Health, Inc. (ARDT) and Encourages Shareholders to Learn More About the Investigation | NYSE:ARDT | Press Release - Stockhouse
Is Ardent Health’s (ARDT) New CEO Appointment a Turning Point for Its Efficiency-Led Strategy? - Sahm
Ardent Health (ARDT) Slips 3% as Stock Tests Support Levels Amid Sector WeaknessKey Reversal Day - newsline.com
A Quick Look at Today's Ratings for Ardent Health(ARDT.US), With a Forecast Between $12 to $13.5 - Moomoo
Ardent Health (ARDT) Slips 3.31% as Resistance Holds, Support Near $8.88 in FocusPullback Trade - newsline.com
Ardent Health (ARDT) Slips 3.31% as Stock Tests Key Support LevelsHedge Fund Exposure - newsline.com
Is Ardent Health Stock a Buy After a Director Purchased More Than 11,000 Shares? - Yahoo Finance
Is Ardent Health Stock a Buy After a Director Purchased More Than 11,000 Shares? - The Motley Fool
Ardent Health Q1 2026 Earnings: EPS Beat of 48.62% Overshadowed by Stock DeclinePretax Income Report - newsline.com
Bronstein, Gewirtz & Grossman, LLC Encourages Ardent Health, Inc. (ARDT) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Chutes & Ladders—AMA elects its next president; Ardent Health appoints new CEO - Fierce Healthcare
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ardent Health, Inc. (ARDT) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Ardent Health Q1 2026 Earnings: Strong EPS Beat Drives Positive Stock ReactionEarnings Miss Alert - newsline.com
symbol__ Stock Quote Price and Forecast - CNN
Insider Buying: Alfred Lumsdaine Acquires Shares of Ardent Healt - GuruFocus
Ardent health director Robert DeMichiei buys $98,299 in stock By Investing.com - Investing.com South Africa
Ardent health CFO Alfred Lumsdaine buys $88,100 in company stock By Investing.com - Investing.com South Africa
Ardent health CFO Alfred Lumsdaine buys $88,100 in company stock - Investing.com India
Ardent health director Robert DeMichiei buys $98,299 in stock - Investing.com
Ardent Health (ARDT) director adds 11,260 shares in open-market buy - Stock Titan
Ardent Health (ARDT) CFO boosts stake with 10,000-share purchase - Stock Titan
Ardent Health, Inc. Stock 12‑Month Price Target Cut to $12.41, Implies 43% Upside - TradingView
Ardent Health, Inc. (ARDT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Will Ardent Health’s (ARDT) New CEO Shift the Focus of Its Post-IPO Efficiency Narrative? - Yahoo Finance
2026-06-07 | Ardent Health, Inc. (ARDT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NYSE:ARDT | Press Release - Stockhouse
A Look At Ardent Health (ARDT) Valuation As New CEO Dave Caspers Takes The Helm - Yahoo Finance
Ardent Health (ARDT) Edges Higher on Modest Volume as Stock Tests Mid-Range LevelsOption Strike Build - newsline.com
BofA raises Ardent Health stock price target on strong Q1 results - Investing.com
Ardent Health Award Spotlights AI Focus As Valuation And Margins Questioned - Sahm
Bronstein, Gewirtz & Grossman, LLC Is Investigating Ardent Health, Inc. (ARDT) And Encourages Investors to Connect - The National Law Review
CEO Bonick Leaves Hospital Operator Ardent - HCI Innovation Group
Ardent Health Names Dave Caspers CEO Amid Transformation - The Globe and Mail
Goldman Sachs health conference to feature Ardent Health webcast on June 10 - Stock Titan
Ardent Health to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference - Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
New Ardent Health CEO inherits growth ambitions - Healthcare Dive
Why is Ardent Health Partners stock plunging today? - Investing.com
Why is Ardent Health Partners stock plunging today? By Investing.com - Investing.com Canada
Ardent Health Appoints Dave Caspers as CEO, Reaffirms 2026 EBITDA Guidance and Focuses on Operational Growth 12 - Minichart
Ardent Health Partners stock hits 52-week low at $7.93 - Investing.com
Finanzdaten der Ardent Health Inc-Aktie (ARDT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.63%
0.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):